Second Nature Care Blog

Depression News - Current Medical Treatments

[fa icon="calendar'] Dec 7, 2015 10:00:00 AM / by Dr. Isadora Guggenheim

Depression News - Current Medical Treatments

It's that time of year around the holidays when we need to talk about sobering topics like depression which can affect anyone at any time. Depression seems to peak around the holidays and seasonal affect disorder runs throughout the darker winter months. 

Recent study findings:

People with diagnosed heart failure who took anti-depressants did have an increased risk for all-cause and cardiovascular disease mortality. Researchers need to further study the effect of anti-depressants on cardiac function and mortality. 

Esketamine or Special K has been studied in patients who have treatment resistant depression. Patients in the study received I.V. infusions of either esketamine 0.20 or 0.40 mg/kg. 

Did it work? Esketamine showed a rapid and robust anti-depressant effect within 2 hours, but there were some side effects: headache, nausea and some transient dissociation. 

We offer specialized I.V. amino acid drips for mood disorders along with diet and strategic nutraceuticals proven to impact brain chemistry.

Book Today!

Who seeks treatment for depression?

According to one study women and people who suffered from high levels of depressive symptoms, frequent episodes and long episodes in duration with consecutive high distress and daily impairments. 

Light therapy alone and in combination with fluoxetine hydrochloride compared to a sham placebo used in adults with major depressive disorders was efficacious and well-tolerated. Combination therapy had the most consistent effects.

miRNA are genes that play a critical role in higher brain functioning. Depressed individuals have marked changes in miRNA expression in the brain. miRNAs are present in circulating blood and can be detected easily. Profiling for miRNAs in serum blood can be used as possible diagnostic therapeutic tools. The aim of this study, which is part of the Helsinki Psychotherapy Study, is to assess the cost–effectiveness of two short–term therapies compared to that of a long–term therapy. Findings suggest that the long–term therapy can hardly be regarded as cost–effective compared to short–term therapies when patients are randomized to the therapy groups.

Lastly, short-term psychotherapy was compared to long-term psychotherapy for mood and or anxiety disorders. Recovery was faster in short-term therapy, but calculating improvements during a 5-year follow-up period the effectiveness of long-term psychotherapy was greater. No surprise!

/blog/depression-in-your-gut-intestinal-microbiome-second-nature-care

/blog/vitamin-d-levels-predict-depression-second-nature-care

/blog/new-rx-for-anxiety-and-depression

Isadora Guggenheim, ND, FNP, RN, MS, CNS, LMT, owner of Second Nature Naturopathic Care, LLC
For all appointments: Tel: 845 358-8385 Fax: 845 358-2963 drguggenheim@msn.com